ArticleOncotarget2023

Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells.

Astha Lamichhane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.